Abstract: A ceramic composition having a high adsorptive capacity for oxygen at elevated temperature, including at least one of: Bi2−yEryO3−d; Bi2−yYyO3−d; La1−yBayCo1−xNixO3−d; La1−ySryCo1−xNixO3−d; La1−yCayCo1−xNixO3−d; La1−yBayCo1−xFexO3−d; La1−ySryCo1−xFexO3−d; and La1−yCayCo1−xFexO3−d; wherein x is from 0.2 to 0.8, y is from 0 to 1.0 and d=0.1 to 0.9. Such ceramic composition may be made using a modified Pechini synthetic procedure. The resulting ceramic composition is usefully employed as an adsorbent for separation of oxygen from an oxygen-containing feed gas mixture, e.g., in a pressure swing adsorption (PSA) process.

Abstract: A pressure swing adsorption system for processing an oxygen-containing feed gas mixture to extract oxygen therefrom, comprising an adsorbent bed arranged for elevated temperature sorption/desorption operation, wherein the adsorbent bed comprises a ceramic adsorbent having affinity for oxygen when the ceramic adsorbent is at elevated temperature. Suitable ceramic adsorbents include lanthanum calcium cobalt ferrites and other oxygen ionic transport ceramic metal oxide compositions. As applied to the separation of air or other oxygen/nitrogen mixtures, the PSA system is effective to produce oxygen-rich as well as nitrogen-rich product gases.

Abstract: The present invention provides a method of inhibiting tumor progression in an individual in need of such treatment, comprising the step of administering to said individual a pharmacologically effective dose of a phospholipase C inhibitor. Also provided is a method of inhibiting metastasis in an individual in need of such treatment, comprising the step of administering to said individual a pharmacologically effective dose of a phospholipase C inhibitor. Further provided are pharmaceutical compositions, comprising a phospholipase C inhibitor of tumor invasiveness and metastasis and a pharmaceutically acceptable carrier and a pharmaceutical composition, comprising a phospholipase C inhibitor of tumor invasiveness and metastasis, a antineoplastic agent and a pharmaceutically acceptable carrier.

Abstract: An implantable cardiac defibrillator is provided. The implantable cardiac defibrillator includes a can, a storage cell for powering the defibrillator, and a circuit module disposed in the can for controlling the defibrillator. The circuit module has a first substrate, a first die coupled to the first substrate, a second die, and a second substrate coupled to and disposed between the first die and the second die. The second substrate has a first plurality of conductors to carry electrical signals to and from the first die and a second plurality of conductors to carry electrical signals to and from the second die. The die may be any of a number of types of electronic components, such as power transistors, memory chips, or others. The stacking of the die saves board space, allowing for further miniaturization or incorporation of additional electronic components.

Abstract: In the design of the process to machine discrete mechanical parts, the sequence of removing material is arrived at to ensure that the resulting part is of the correct geometry and finish, and the process is safe, feasible and accomplished in minimum time. For complex parts, an experienced machinist makes use of inductive methods to relate similar part material, geometries together with interdependencies and their associated machining sequences which have produced quality parts in the past with minimum time expended, or deductive methods to generate a sequence by relating feature attributes (relative size and position) and relations (intersections and common tooling). Of interest is the interaction between the two methods because their coupling enables a self-improving design system to be realized. A feature-based solid modelling software environment provides the elements of a symbolic language for describing a discrete mechanical part in terms of its product and process design.